| XMD17 109 |
XMD17 109 |
1435488-37-1 |
| HLCL-61 (hydrochloride) |
无中文名称 |
1158279-20-9 |
| 3--Phenyl-N-(2,2,2-trichloro-1-((((4-chlorophenyl)amino)carbonothioyl)amino)ethyl)acrylamide |
(2E)-3-苯基-N-[2,2,2-三氯-1-[[[(4-氯苯基)氨基]硫代甲酰基]氨基]乙基]-2-丙烯酰胺 |
1164470-53-4 |
| CH5132799 |
CH5132799 |
1007207-67-1 |
| JZL 184 |
JZL-184 |
1101854-58-3 |
| LY2584702 |
LY-2584702 |
1082949-67-4 |
| BAZEDOXIFENE ACETATE |
醋酸巴多昔芬 |
198481-33-3 |
| Wnt Agonist |
WNT AGONIST 1 (CID11210285 盐酸盐) |
853220-52-7 |
| TLX agonist 1 |
TLX agonist 1 |
958323-31-4 |
| PD04217903 |
2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇 |
956905-27-4 |
| Danirixin |
GSK1325756 |
954126-98-8 |
| LY2409881 trihydrochloride |
IKK2抑制剂（LY2409881） |
946518-60-1 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 |
936890-98-1 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
| 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine |
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
935666-88-9 |
| Mycro3 |
944547-46-0 |
944547-46-0 |
| 3-CinnolinecarboxaMide, 4-aMino-8-(2-fluoro-6-Methoxyphenyl)-N-propyl- |
3-CinnolinecarboxaMide, 4-aMino-8-(2-fluoro-6-Methoxyphenyl)-N-propyl- |
942437-37-8 |
| N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-14-4 |
| N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-26-8 |
QQ
微信
